| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |